Kraus & Lederer Partgmbb opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Kraus & Lederer Partgmbb

Patent Number:
Title:
Tablets Comprising Tamsulosin And Solifenacin
Applicant:
Opposition Date:
Aug 13, 2024
Patent Number:
Title:
Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex
Opposition Date:
Jul 9, 2024
Patent Number:
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Opposition Date:
Jun 13, 2024
Patent Number:
Title:
Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule
Opposition Date:
Apr 30, 2024
Patent Number:
Title:
Chemical Compound Useful As Intermediate For Preparing A Catechol-0-Methyl Transferase Inhibitor
Opposition Date:
Apr 26, 2024
Patent Number:
Title:
Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant
Opposition Date:
Apr 18, 2024
Patent Number:
Title:
Isopentyl Esters For The Use In Cosmetic, Dermatological, Or Pharmaceutical Compositions
Opposition Date:
Mar 7, 2024
Patent Number:
Title:
Holder For Paper Roll And Tamper-Proof End Piece For Paper Roll
Applicant:
Opposition Date:
Mar 6, 2024
Patent Number:
Title:
Gip/Glp1 Agonist Compositions
Opposition Date:
Mar 5, 2024
Patent Number:
Title:
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate
Applicant:
Opposition Date:
Feb 9, 2024

Want to track Kraus & Lederer Partgmbb?

Feel free to send us a message here and we will get back to you